User profiles for M. Bauer

Michael Bauer

- Verified email at uniklinikum-dresden.de - Cited by 54525

Michael Bauer

- Verified email at rockefeller.edu - Cited by 1509

[HTML][HTML] A minimal common outcome measure set for COVID-19 clinical research

…, M Bauer, S Berry, B Blackwood, M Bonten… - The lancet infectious …, 2020 - thelancet.com
Clinical research is necessary for an effective response to an emerging infectious disease
outbreak. However, research efforts are often hastily organised and done using various …

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

…, G Monneret, F Venet, M Bauer… - The Lancet …, 2021 - thelancet.com
The zoonotic SARS-CoV-2 virus that causes COVID-19 continues to spread worldwide, with
devastating consequences. While the medical community has gained insight into the …

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

J Kirchheiner, K Nickchen, M Bauer, ML Wong… - Molecular …, 2004 - nature.com
Genetic factors contribute to the phenotype of drug response. We systematically analyzed
all available pharmacogenetic data from Medline databases (1970–2003) on the impact that …

The third international consensus definitions for sepsis and septic shock (Sepsis-3)

…, CW Seymour, M Shankar-Hari, D Annane, M Bauer… - Jama, 2016 - jamanetwork.com
Importance Definitions of sepsis and septic shock were last revised in 2001. Considerable
advances have since been made into the pathobiology (changes in organ function, …

Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms

…, SM Owens, J Betley, L Fraser, M Bauer… - The ISME …, 2012 - academic.oup.com
DNA sequencing continues to decrease in cost with the Illumina HiSeq2000 generating up
to 600 Gb of paired-end 100 base reads in a ten-day run. Here we present a protocol for …

Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact

GM Curran, M Bauer, B Mittman, JM Pyne… - Medical care, 2012 - journals.lww.com
Objectives: This study proposes methods for blending design components of clinical
effectiveness and implementation research. Such blending can provide benefits over pursuing …

Exclusive semileptonic decays of heavy mesons

M Wirbel, B Stech, M Bauer - Zeitschrift für Physik C Particles and Fields, 1985 - Springer
… The function ~,, describes the internal wave function of a meson of mass m for two quark
constituents. Since we do not consider any extra gluon component, these effective quarks carry …

Efficacy of climate forcings

…, G Russell, I Aleinov, M Bauer, S Bauer… - Journal of …, 2005 - Wiley Online Library
We use a global climate model to compare the effectiveness of many climate forcing agents
for producing climate change. We find a substantial range in the “efficacy” of different forcings…

Neuropilin-1 is a host factor for SARS-CoV-2 infection

…, DK Shoemark, L Simón-Gracia, M Bauer… - Science, 2020 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), uses the viral spike (S) protein for host cell attachment …

Exclusive non-leptonic decays ofD-,Ds- andB-mesons

M Bauer, B Stech, M Wirbel - Zeitschrift für Physik C Particles and Fields, 1987 - Springer
Recent experimental results onD-,D s - andB-decays are interpreted on the basis of the
valence quark model. For nonleptonic decays generally good results are obtained using …